Aramark Extra Strength Acetaminophen
- Manufacturer
- Western First Aid Safety DBA Aramark | ULTRA SEAL CORPORATION
- Effective date
- 2021-07-19
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-05-31 23:45:38
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Drug Facts
Active Ingredient (in each tablet)
Acetaminophen 500 mg
OTC - PURPOSE SECTION
Purpose
Acetaminophen ...................Pain Reliever/Fever Reducer
INDICATIONS & USAGE SECTION
Uses:
Temporarily Relieves minor aches and pains
due to:
• Headache, toothaches, menstrual cramps,
the common cold,
• muscular aches, minor pain of arthritis
Temporarily reduces fever
WARNINGS SECTION
Warnings:
Allergy Alert: Acetaminophen may cause a severe skin
reactions.
Symptoms may include:
• Skin reddening •Blisters •Rash
• If a skin reaction occurs, stop use and seek medical
right away.
Liver Warning: This product contains an
acetaminophen. Severe liver damage may occur if you
take:
• more than 8 tablets in 24 hours, which is the
maximum daily amount
• 3 or more alcoholic drinks every day while using this
product
• take more or for a longer time than directed
OTC - DO NOT USE SECTION
Do not use:
• if you have ever had an allergic reaction to any
other pain
• reliever/fever reducer
• right before or after heart surgery
• if you have ever had an allergic reaction to this
product or any of its ingredients
OTC - ASK DOCTOR SECTION
Ask a doctor before use if:
• you have liver disease
OTC - ASK DOCTOR/PHARMACIST SECTION
Ask a doctor or pharmacist before use if you are:
• under a doctor’s care for any serious condition
• taking the blood thinning drug Warfarin
OTC - WHEN USING SECTION
When using this product:
• take with food or milk if stomach upset occurs
• the risk of heart attack or stroke may increase if
you use more than directed or for longer than
directed
OTC - STOP USE SECTION
Stop use and ask a doctor if:
• pain gets worse lasts more than 10 days
• feel faint
• pain gets worse or lasts more than 10 days
• fever gets worse or lasts more than 3 days
• redness or swelling is present in the painful area
• any new symptoms occur
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a health
professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. In case of overdose,
get medical help or contact a Poison Control Center
right away. Prompt medical attention is critical for
adults as well as for children even if you do not
notice any signs or symptoms.
DOSAGE & ADMINISTRATION SECTION
Directions:
• do not take more than directed
• adults and children 12 years and over: take 2
tablets every 4 to 6 hours as needed
• do not exceed 8 tablets in 24 hours, unless
directed by a doctor
• Children under 12 years: Do not use this product
OTHER SAFETY INFORMATION
Other information:
read all warnings and directions before use. Keep
carton. Store at 20-25°C (68-77°F) avoid excessive
heat above 40°C (104°F)
INACTIVE INGREDIENT SECTION
Inactive Ingredients:
Microcrystalline Cellulose, Povidone, Sodium Starch
Glycolate, Starch, Stearic Acid
Package Labeling
aramark
100 TABLETS Part # 90433B
PER BOX
Extra Strength
Acetaminophen
Pain Reliever/Fever Reducer
Temporary relief of minor aches and
pains associated with a cold,
headache, tootache, muscular aches,
and for the reduction of fever
Compare active ingredient to:
Extra Strength Tylenol®
Registered Trademark of Johnson & Johnson
MANUFACTURED FOR:
Aramark
Lenexa, KS 66219
866-362-2691
aramarkuniform.com
Retain carton for complete product information
100 Tablet Box
250 Tablet Box
2-Tablet Packet
res
DailyMed RxNorm Mappings#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 81238-3500-1 | 2023-01-30 | C162847 | 48780-1 | f386c649-f4c1-0266-e053-dadaa90a7c1a | Aramark Extra Strength Acetaminophen |
| 81238-3500-2 | 2023-01-30 | C162847 | 48780-1 | f386c649-f4c1-0266-e053-dadaa90a7c1a | Aramark Extra Strength Acetaminophen |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 81238-3500-1 | Aramark Extra Strength Acetaminophen | 2 in 1 PACKET | TABLET | 2 | 2 | |
| 81238-3500-1 | Aramark Extra Strength Acetaminophen | 50 in 1 BOX | TABLET | 50 | 2 | |
| 81238-3500-2 | Aramark Extra Strength Acetaminophen | 125 in 1 BOX | TABLET | 125 | 2 | |
| 81238-3500-2 | Aramark Extra Strength Acetaminophen | 2 in 1 PACKET | TABLET | 2 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 81238-3500 | ARAMARK EXTRA STRENGTH ACETAMINOPHEN (ACETAMINOPHEN) TABLET [WESTERN FIRST AID SAFETY DBA ARAMARK] | 2 | Legacy NDC, 4 package rows | 20211215_9bf4ca22-2546-4803-a199-b7d782e04a97.zip |
Products#
Every source-derived product name is available through these pages.
- Aramark Extra Strength Acetaminophen
- ACETAMINOPHEN
- MICROCRYSTALLINE CELLULOSE
- POVIDONE
- SODIUM STARCH GLYCOLATE TYPE A CORN
- STARCH, CORN
- STEARIC ACID
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 81238-3500 | 81238-3500-1, 81238-3500-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ACETAMINOPHEN | 362O9ITL9D | ACTIB |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| POVIDONE | FZ989GH94E | IACT |
| SODIUM STARCH GLYCOLATE TYPE A CORN | AG9B65PV6B | IACT |
| STARCH, CORN | O8232NY3SJ | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 1114224d-5c96-43e0-aa89-bb7b1550be47 | 9bf4ca22-2546-4803-a199-b7d782e04a97 | 2021-07-19 | Warnings | 1114224d-5c96-43e0-aa89-bb7b1550be47 9bf4ca22-2546-4803-a199-b7d782e04a97 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.


